Navigation Links
St. Joseph's Hospital and InNexus Biotechnology Enter Collaborative Partnership
Date:9/19/2008

- Focusing on Development of Treatments For Women with Endometriosis -

PHOENIX and BRITISH COLUMBIA, Canada, Sept. 19 /PRNewswire-FirstCall/ -- St. Joseph's Hospital and Medical Center, part of Catholic Healthcare West, one of the largest healthcare systems in the West with 42 hospitals in Arizona, California and Nevada and InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announces a collaborative partnership focusing on the development of treatments for women with endometriosis.

"I am pleased to announce this new partnership between St. Joseph's Hospital and InNexus to explore, develop and commercialize new therapeutic solutions for women," said Jeff Morhet, Chairman and CEO of InNexus Biotechnology, "We've already identified our first project, aimed at providing new treatments to attack the problem of endometriosis, a painful condition that can lead to other conditions, such as infertility."

"We're excited to join InNexus in pursuing new treatments to help women with endometriosis," says Linda Hunt, President of St. Joseph's. "We hope this is the first of many collaborations that will ultimately help patients in need."

Scientific activities of the partnership will be conducted in facilities of both St. Joseph's Hospital and Medical Center and InNexus' GLP (Good Lab Practice) certified drug development laboratories with funding provided by research grants, the partners and strategic collaborators. Additional details were not disclosed.

About Endometriosis

According to the National Institutes of Health, endometriosis occurs when tissues that usually grow inside the uterus instead grow on the outside. These tissues often grow on the surfaces of organs in the pelvis or abdomen, whe
'/>"/>

SOURCE InNexus Biotechnology Inc.; St. Joseph's Hospital andMedical Center
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
2. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
3. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
4. States First Single Incision Robotic Kidney Removal Performed at Henry Ford Hospital
5. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
6. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
7. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
8. U.S. Hospital Sales Opportunities Maximized Through Functional Optimization
9. Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide
10. St. Lukes Episcopal Hospital to Add CyberKnife System to Treatment Offerings
11. FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... EpiVax, Inc. today annou... (SIX: RO, ROG; OTCQX: RHHBY) aimed at evaluating ...hich could potentially reduce detrimental immune r...che-EpiVax collaboration, the EpiVax Tregitope tec...mmunogenicity of protein therapeutics. , ...
(Date:12/1/2009)..., , CRANBURY, N.J., Dec. 1 /PRNewswire-Fir... PTN ) today announced that the U.S. Patent and Tr...0, titled "Cyclic Natriuretic Peptide Constructs."...f cyclic compounds that bind to natriuretic peptid...lead heart failure drug candidate. ,, "Our natr...
(Date:12/1/2009)..., , HUNTINGTON BEACH, California ... a world leader in molecular cancer diagnostics, a...t B Medicare administrator, has established,coding...maPrint is Agendia,s,FDA-cleared breast cancer rec...since 2008. , Patients across the United ...
(Date:12/1/2009)..., , HARBIN, China, Dec. 1 /PRN...Inc. ("China Sky One Medical" or "the Company") (N...eutical company developing and producing,over-the-...PRC"), today,announced that the Company has engage...Service Company ("MDK") to serve as its exclusive ...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3
.... 29 Allos,Therapeutics, Inc. (Nasdaq: ALTH ), a...ent and commercialization of small molecule therap...d that members of the Company,s,senior management ...ill,Lynch Global Pharmaceutical, Biotechnology and...any,s presentation will take place at 11:00 a.m. (...
...swire/ - Viventia Biotech Inc., a privately held,b...novel antibody,therapeutics focused on cancer, ann...natives to further advance and realize value from ...dy discovery platform and its,antibody manufacturi...al,strategic opportunities including, but not limi...
...to Canadian HAI Market; Market Expenditures for MR...llion by 2012, SUNNYVALE, Calif., Jan. 29 Cephei...a has issued a medical device,license for the Xper...llin,Resistant Staphylococcus aureus (MRSA) on nas...est results are available in approximately 70 minu...
Other Biology Technology:Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 2Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 2Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 3Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 4Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 5Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data 6Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 2Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 3Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System 4
(Date:12/1/2009)...Ben-Ari, winner of the 2009 Inserm Grand Prix., ...mitment to paying tribute to outstanding,work per...ouring talents, Inserm intends to,demonstrate the...day,s biological, medical and,health research, an...who carry out and,drive this research each day. T...
(Date:12/1/2009)...LE, Fla. Hit-and-run attacks by sharks can be sol...its by the unique chomp they put on their victims,...nd shark expert. , In a method analogous to anal...tifications by precisely comparing shark bites to ... George Burgess, director of the International Sha...
(Date:12/1/2009)...d first, a Monash University-led international res...t the output of the next generation of solar cells...ation with colleagues from the universities of Wol...ye-sensitised solar cells with a three-fold increa...reviously reported tandem dye-sensitised solar cel...
Breaking Biology News(10 mins):Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Innovation puts next-generation solar cells on the horizon 2Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 1Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 2VisionDirect com Offers Contact Lens Customers a New Way to Pay 48307 1VisionDirect com Offers Contact Lens Customers a New Way to Pay 48307 2VisionDirect com Offers Contact Lens Customers a New Way to Pay 48307 3Accumetrics Inc Announces Distribution Channels in Israel and Cyprus 48302 1Accumetrics Inc Announces Distribution Channels in Israel and Cyprus 48302 2
...cientists has discovered three molecules –?from a ...t a key perpetrator of Alzheimer,s disease. , Each...d "tau," which becomes hopelessly tangled in the b... promising news for the development of drugs for t...science Research Institute at the University of Ca...
...may have found a way to dramatically slow organ tr... That,s the promising implication of an animal stu... Alabama at Birmingham (UAB) and the University of...f Proceedings of the National Academy of Sciences....ified the biological pathway of a potent molecule ...
... have reported findings that offer a surprising ne...vital floral pollinator, select the flowers from w...ar plants, foraging bees do not choose flowers ent...bees. The new findings suggest that bees adjust th...ar plant species. , The observations are reported ...
Other Biology News:Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels 2Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels 3Discoveries by UAB and Florida scientists may help transplanted organs survive longer 2
...uct has been developed to significantly increase t...ns. Stability is increased at room temperature st...his product is subjected to 0.45 micron filtration...ion insures consistently high levels of activity f...
...atic I provides a convenient and affordable altern... Used with an eight-port disposable manifold, the ...ible with multi-channel pipettes. The eight-port m...s fluids in volumes of 100, 200, 250, or 300mL wit...
Corning brand cover glass squares, 0.16 to 0.19mm thick from Sigma-Aldrich
...ilm Life Science FLA-8000 Fluorescent Image Analyz...ection in a single laser imaging system. This powe...labeled with fluorescent dyes or radioisotopes at ...g laboratories. Speed, image quality and flexibili...
Biology Products: